CYP21A2 c.1451G>C

CYP21A2 c.1451G>C

The CYP21A2 c.1451G>C Novallele Genotyping Assay identifies a single nucleotide change of the CYP21A2 gene. Mutations of the CYP21A2 gene cause 21-hydroxylase deficiency associated with adrenal hyperplasia. 21-hydroxylase deficiency is an inherited disease that affects the adrenal glands and is characterized by arrhythmias, low blood glucose, and low blood sodium levels.

£177.00

Get in touch

Get in touch with the team

  • :

Product Description

The CYP21A2 c.1451G>C Novallele Genotyping Assay is used to amplify and identify specific genetic polymorphisms or mutations. This assay provides scientists with a simple way to quickly genotype this locus from isolated human genomic DNA. The assay contains functionally-verified oligonucleotide primers and unlabeled probes necessary for PCR and subsequent allele identification by DNA melting. For Research Use Only. Not for use in diagnostic procedures.